Overview

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study compared the blunting effect of aliskiren and valsartan monotherapies on exercise-induced rises in systolic blood pressure in patients with mild to moderate essential hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Valsartan